ID   GGT1_HUMAN              Reviewed;         569 AA.
AC   P19440; Q08247; Q14404; Q8TBS1; Q9UMK1;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 2.
DT   10-MAY-2017, entry version 192.
DE   RecName: Full=Gamma-glutamyltranspeptidase 1 {ECO:0000303|PubMed:2904146};
DE            Short=GGT 1;
DE            EC=2.3.2.2 {ECO:0000269|PubMed:17924658, ECO:0000269|PubMed:7673200, ECO:0000269|PubMed:7759490, ECO:0000269|PubMed:8095045, ECO:0000269|PubMed:8827453};
DE   AltName: Full=Gamma-glutamyltransferase 1;
DE   AltName: Full=Glutathione hydrolase 1;
DE            EC=3.4.19.13 {ECO:0000269|PubMed:17924658};
DE   AltName: Full=Leukotriene-C4 hydrolase;
DE            EC=3.4.19.14 {ECO:0000250|UniProtKB:P07314};
DE   AltName: CD_antigen=CD224;
DE   Contains:
DE     RecName: Full=Gamma-glutamyltranspeptidase 1 heavy chain;
DE   Contains:
DE     RecName: Full=Gamma-glutamyltranspeptidase 1 light chain;
DE   Flags: Precursor;
GN   Name=GGT1; Synonyms=GGT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-272.
RC   TISSUE=Placenta;
RX   PubMed=2904146; DOI=10.1073/pnas.85.23.8840;
RA   Rajpert-De Meyts E., Heisterkamp N., Groffen J.;
RT   "Cloning and nucleotide sequence of human gamma-glutamyl
RT   transpeptidase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:8840-8844(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 30-58 AND
RP   381-408, AND VARIANT ALA-272.
RC   TISSUE=Kidney, and Liver;
RX   PubMed=2907498; DOI=10.1016/0378-1119(88)90307-1;
RA   Sakamuro D., Yamazoe M., Matsuda Y., Kangawa K., Taniguchi N.,
RA   Matsuo H., Yoshikawa H., Ogasawara N.;
RT   "The primary structure of human gamma-glutamyl transpeptidase.";
RL   Gene 73:1-9(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-272.
RX   PubMed=2563599; DOI=10.1016/0041-008X(89)90052-5;
RA   Pitot H.C., Goodspeed D.C., Dunn T.J., Hendrich S., Maronpot R.R.,
RA   Moran S.;
RT   "Regulation of the expression of some genes for enzymes of glutathione
RT   metabolism in hepatotoxicity and hepatocarcinogenesis.";
RL   Toxicol. Appl. Pharmacol. 97:23-34(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-272.
RC   TISSUE=Hepatoblastoma;
RX   PubMed=2568315; DOI=10.1016/0378-1119(89)90002-4;
RA   Goodspeed D.C., Dunn T.J., Miller C.D., Pitot H.C.;
RT   "Human gamma-glutamyl transpeptidase cDNA: comparison of hepatoma and
RT   kidney mRNA in the human and rat.";
RL   Gene 76:1-9(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT ALA-272.
RC   TISSUE=Liver;
RX   PubMed=1968061;
RA   Pawlak A., Cohen E.H., Octave J.-N., Schweickhardt R., Wu S.-J.,
RA   Bulle F., Chikhi N., Baik J.-H., Siegrist S., Guellaen G.;
RT   "An alternatively processed mRNA specific for gamma-glutamyl
RT   transpeptidase in human tissues.";
RL   J. Biol. Chem. 265:3256-3262(1990).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-272.
RC   TISSUE=Pancreas;
RX   PubMed=1378736; DOI=10.1016/0006-2952(92)90140-E;
RA   Courtay C., Oster T., Michelet F., Visvikis A., Diederich M.,
RA   Wellman M., Siest G.;
RT   "Gamma-glutamyltransferase: nucleotide sequence of the human
RT   pancreatic cDNA. Evidence for a ubiquitous gamma-glutamyltransferase
RT   polypeptide in human tissues.";
RL   Biochem. Pharmacol. 43:2527-2533(1992).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND LACK OF FUNCTION OF
RP   ISOFORM 3.
RC   TISSUE=Lung;
RX   PubMed=7689219; DOI=10.1073/pnas.90.16.7461;
RA   Wetmore L.A., Gerard C., Drazen J.M.;
RT   "Human lung expresses unique gamma-glutamyl transpeptidase
RT   transcripts.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:7461-7465(1993).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 30-48 AND 381-403.
RC   TISSUE=Kidney;
RX   PubMed=2896486; DOI=10.1016/0003-9861(88)90390-6;
RA   Tate S.S., Khadse V., Wellner D.;
RT   "Renal gamma-glutamyl transpeptidases: structural and immunological
RT   studies.";
RL   Arch. Biochem. Biophys. 262:397-408(1988).
RN   [12]
RP   ALTERNATIVE SPLICING, AND ALTERNATIVE PROMOTER USAGE.
RX   PubMed=10392451; DOI=10.1016/S0305-0491(99)00013-9;
RA   Chikhi N., Holic N., Guellaen G., Laperche Y.;
RT   "Gamma-glutamyl transpeptidase gene organization and expression: a
RT   comparative analysis in rat, mouse, pig and human species.";
RL   Comp. Biochem. Physiol. 122B:367-380(1999).
RN   [13]
RP   GLYCOSYLATION, AND SIALIC ACID CONTENT.
RC   TISSUE=Kidney;
RX   PubMed=19463;
RA   Tate S.S., Ross M.E.;
RT   "Human kidney gamma-glutamyl transpeptidase. Catalytic properties,
RT   subunit structure, and localization of the gamma-glutamyl binding site
RT   on the light subunit.";
RL   J. Biol. Chem. 252:6042-6045(1977).
RN   [14]
RP   GLYCOSYLATION.
RX   PubMed=2900635; DOI=10.1016/0006-291X(88)90263-X;
RA   Tate S.S., Galbraith R.A.;
RT   "In vitro translation and processing of human hepatoma cell (Hep G2)
RT   gamma-glutamyl transpeptidase.";
RL   Biochem. Biophys. Res. Commun. 154:1167-1173(1988).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, AUTOCATALYTIC CLEAVAGE, SUBUNIT,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-100; GLU-102; ARG-107;
RP   GLU-108; ARG-112; ARG-139; ARG-147 AND ARG-150.
RX   PubMed=8095045;
RA   Ikeda Y., Fujii J., Taniguchi N.;
RT   "Significance of Arg-107 and Glu-108 in the catalytic mechanism of
RT   human gamma-glutamyl transpeptidase. Identification by site-directed
RT   mutagenesis.";
RL   J. Biol. Chem. 268:3980-3985(1993).
RN   [16]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF ASP-422; ASP-423 AND
RP   CYS-454.
RX   PubMed=7759490; DOI=10.1074/jbc.270.21.12471;
RA   Ikeda Y., Fujii J., Taniguchi N., Meister A.;
RT   "Human gamma-glutamyl transpeptidase mutants involving conserved
RT   aspartate residues and the unique cysteine residue of the light
RT   subunit.";
RL   J. Biol. Chem. 270:12471-12475(1995).
RN   [17]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF SER-385; SER-413;
RP   SER-425; SER-451 AND SER-452.
RX   PubMed=7673200; DOI=10.1074/jbc.270.38.22223;
RA   Ikeda Y., Fujii J., Anderson M.E., Taniguchi N., Meister A.;
RT   "Involvement of Ser-451 and Ser-452 in the catalysis of human gamma-
RT   glutamyl transpeptidase.";
RL   J. Biol. Chem. 270:22223-22228(1995).
RN   [18]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF HIS-383 AND HIS-505.
RX   PubMed=8827453; DOI=10.1093/oxfordjournals.jbchem.a021363;
RA   Ikeda Y., Fujii J., Taniguchi N.;
RT   "Effects of substitutions of the conserved histidine residues in human
RT   gamma-glutamyl transpeptidase.";
RL   J. Biochem. 119:1166-1170(1996).
RN   [19]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-511.
RC   TISSUE=Bile;
RX   PubMed=15084671; DOI=10.1074/mcp.M400015-MCP200;
RA   Kristiansen T.Z., Bunkenborg J., Gronborg M., Molina H.,
RA   Thuluvath P.J., Argani P., Goggins M.G., Maitra A., Pandey A.;
RT   "A proteomic analysis of human bile.";
RL   Mol. Cell. Proteomics 3:715-728(2004).
RN   [20]
RP   CATALYTIC ACTIVITY, ACTIVE SITE, GLYCOSYLATION AT ASN-120; ASN-266;
RP   ASN-344 AND ASN-511, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17924658; DOI=10.1021/bi700956c;
RA   Castonguay R., Halim D., Morin M., Furtos A., Lherbet C., Bonneil E.,
RA   Thibault P., Keillor J.W.;
RT   "Kinetic characterization and identification of the acylation and
RT   glycosylation sites of recombinant human gamma-
RT   glutamyltranspeptidase.";
RL   Biochemistry 46:12253-12262(2007).
RN   [21]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-120; ASN-230 AND ASN-511.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [22]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-120.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [23]
RP   FUNCTION, CATALYTIC ACTIVITY, AND GLYCOSYLATION AT ASN-95; ASN-120;
RP   ASN-230; ASN-266; ASN-297; ASN-344 AND ASN-511.
RX   PubMed=20622017; DOI=10.1074/jbc.M110.145938;
RA   West M.B., Segu Z.M., Feasley C.L., Kang P., Klouckova I., Li C.,
RA   Novotny M.V., West C.M., Mechref Y., Hanigan M.H.;
RT   "Analysis of site-specific glycosylation of renal and hepatic gamma-
RT   glutamyl transpeptidase from normal human tissue.";
RL   J. Biol. Chem. 285:29511-29524(2010).
RN   [24]
RP   CATALYTIC ACTIVITY, AUTOCATALYTIC CLEAVAGE, ENZYME REGULATION,
RP   SUBCELLULAR LOCATION, GLYCOSYLATION, AND MUTAGENESIS OF CYS-192 AND
RP   GLU-193.
RX   PubMed=23682772; DOI=10.1089/ars.2012.4997;
RA   West M.B., Wickham S., Parks E.E., Sherry D.M., Hanigan M.H.;
RT   "Human GGT2 does not autocleave into a functional enzyme: a cautionary
RT   tale for interpretation of microarray data on redox signaling.";
RL   Antioxid. Redox Signal. 19:1877-1888(2013).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (1.67 ANGSTROMS) IN COMPLEX WITH GLUTAMATE AND
RP   CHLORIDE IONS, FUNCTION, CATALYTIC ACTIVITY, AUTOCATALYTIC CLEAVAGE,
RP   SUBUNIT, MUTAGENESIS OF GLN-545, DISULFIDE BONDS, AND GLYCOSYLATION AT
RP   ASN-95; ASN-120; ASN-230; ASN-266; ASN-344 AND ASN-511.
RX   PubMed=24047895; DOI=10.1074/jbc.M113.498139;
RA   West M.B., Chen Y., Wickham S., Heroux A., Cahill K., Hanigan M.H.,
RA   Mooers B.H.;
RT   "Novel insights into eukaryotic gamma-glutamyl transpeptidase 1 from
RT   the crystal structure of the glutamate-bound human enzyme.";
RL   J. Biol. Chem. 288:31902-31913(2013).
CC   -!- FUNCTION: Cleaves the gamma-glutamyl bond of extracellular
CC       glutathione (gamma-Glu-Cys-Gly), glutathione conjugates, and other
CC       gamma-glutamyl compounds. The metabolism of glutathione releases
CC       free glutamate and the dipeptide, cysteinyl-glycine, which is
CC       hydrolyzed to cysteine and glycine by dipeptidases. In the
CC       presence of high concentrations of dipeptides and some amino
CC       acids, can also catalyze a transpeptidation reaction, transferring
CC       the gamma-glutamyl moiety to an acceptor amino acid to form a new
CC       gamma-glutamyl compound. Initiates extracellular glutathione (GSH)
CC       breakdown, provides cells with a local cysteine supply and
CC       contributes to maintain intracellular GSH level. It is part of the
CC       cell antioxidant defense mechanism. Isoform 3 seems to be
CC       inactive. {ECO:0000269|PubMed:20622017,
CC       ECO:0000269|PubMed:24047895, ECO:0000269|PubMed:7673200,
CC       ECO:0000269|PubMed:7759490, ECO:0000269|PubMed:8095045,
CC       ECO:0000269|PubMed:8827453}.
CC   -!- CATALYTIC ACTIVITY: A (5-L-glutamyl)-peptide + an amino acid = a
CC       peptide + a 5-L-glutamyl amino acid. {ECO:0000269|PubMed:17924658,
CC       ECO:0000269|PubMed:7673200, ECO:0000269|PubMed:7759490,
CC       ECO:0000269|PubMed:8095045, ECO:0000269|PubMed:8827453}.
CC   -!- CATALYTIC ACTIVITY: Glutathione + H(2)O = L-cysteinylglycine + L-
CC       glutamate. {ECO:0000269|PubMed:17924658}.
CC   -!- CATALYTIC ACTIVITY: Leukotriene C(4) + H(2)O = leukotriene D(4) +
CC       L-glutamate. {ECO:0000250|UniProtKB:P07314}.
CC   -!- ENZYME REGULATION: Activated by autocatalytic cleavage.
CC       {ECO:0000269|PubMed:23682772}.
CC   -!- PATHWAY: Sulfur metabolism; glutathione metabolism.
CC   -!- SUBUNIT: Heterodimer composed of the light and heavy chains. The
CC       active site is located in the light chain.
CC       {ECO:0000269|PubMed:24047895, ECO:0000269|PubMed:8095045}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23682772,
CC       ECO:0000269|PubMed:8095045}; Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:23682772, ECO:0000269|PubMed:8095045}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P19440-1; Sequence=Displayed;
CC         Note=Produced by alternative promoter usage.;
CC       Name=2;
CC         IsoId=P19440-2; Sequence=VSP_001746, VSP_001747;
CC         Note=Produced by alternative splicing of isoform 1.;
CC       Name=3;
CC         IsoId=P19440-3; Sequence=VSP_008132;
CC         Note=Produced by alternative promoter usage.;
CC   -!- TISSUE SPECIFICITY: Detected in fetal and adult kidney and liver,
CC       adult pancreas, stomach, intestine, placenta and lung. Isoform 3
CC       is lung-specific. There are several other tissue-specific forms
CC       that arise from alternative promoter usage but that produce the
CC       same protein.
CC   -!- PTM: N-glycosylated on both chains. Contains hexoses, hexosamines
CC       and sialic acid residues. Glycosylation profiles tested in kidney
CC       and liver tissues reveal the presence of tissue-specific and site-
CC       specific glycan composition, despite the overlap in composition
CC       among the N-glycans. A total of 36 glycan compositions, with 40
CC       unique structures are observed. Up to 15 different glycans are
CC       observed at a single site, with site-specific variation in glycan
CC       composition. The difference in glycosylation profiles in the 2
CC       tissues do not affect the enzyme activity.
CC       {ECO:0000269|PubMed:15084671, ECO:0000269|PubMed:17924658,
CC       ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19349973,
CC       ECO:0000269|PubMed:19463, ECO:0000269|PubMed:20622017,
CC       ECO:0000269|PubMed:23682772, ECO:0000269|PubMed:24047895,
CC       ECO:0000269|PubMed:2900635}.
CC   -!- PTM: Cleaved by autocatalysis into a large and a small subunit and
CC       the autocatalytic cleavage is essential to the functional
CC       activation of the enzyme.
CC   -!- DISEASE: Glutathionuria (GLUTH) [MIM:231950]: Autosomal recessive
CC       disease. Note=The disease is caused by mutations affecting the
CC       gene represented in this entry.
CC   -!- MISCELLANEOUS: Cys-454 was thought to bind the gamma-glutamyl
CC       moiety, but mutagenesis of this residue had no effect on activity.
CC   -!- MISCELLANEOUS: Chloride ions bound in the active site cavity may
CC       contribute to stabilize the protein fold.
CC   -!- SIMILARITY: Belongs to the gamma-glutamyltransferase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA35899.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Gamma-glutamyl transpeptidase
CC       entry;
CC       URL="https://en.wikipedia.org/wiki/Gamma_glutamyl_transpeptidase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J04131; AAA52547.1; -; mRNA.
DR   EMBL; M24087; AAA35899.1; ALT_INIT; mRNA.
DR   EMBL; M24903; AAA52546.1; -; mRNA.
DR   EMBL; J05235; AAA35889.1; -; mRNA.
DR   EMBL; X60069; CAA42674.1; -; mRNA.
DR   EMBL; L20490; AAA02884.1; -; mRNA.
DR   EMBL; L20493; AAA02886.1; -; mRNA.
DR   EMBL; CR456494; CAG30380.1; -; mRNA.
DR   EMBL; AP000356; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC025927; AAH25927.1; -; mRNA.
DR   EMBL; BC069473; AAH69473.1; -; mRNA.
DR   EMBL; BC069504; AAH69504.1; -; mRNA.
DR   EMBL; BC128238; AAI28239.1; -; mRNA.
DR   EMBL; BC128239; AAI28240.1; -; mRNA.
DR   CCDS; CCDS42992.1; -. [P19440-1]
DR   PIR; A31253; EKHUEX.
DR   PIR; A48987; A48987.
DR   PIR; A60439; A60439.
DR   PIR; JS0067; JS0067.
DR   PIR; PS0312; PS0312.
DR   RefSeq; NP_001275762.1; NM_001288833.1. [P19440-1]
DR   RefSeq; NP_038265.2; NM_013421.2. [P19440-1]
DR   RefSeq; NP_038347.2; NM_013430.2. [P19440-1]
DR   UniGene; Hs.595809; -.
DR   UniGene; Hs.645535; -.
DR   PDB; 4GDX; X-ray; 1.67 A; A=2-374, B=375-569.
DR   PDB; 4GG2; X-ray; 2.21 A; A=28-380, B=381-569.
DR   PDB; 4Z9O; X-ray; 2.30 A; A=28-380, B=381-569.
DR   PDB; 4ZBK; X-ray; 2.18 A; A=28-380, B=381-569.
DR   PDB; 4ZC6; X-ray; 2.10 A; A=28-380, B=381-569.
DR   PDB; 4ZCG; X-ray; 2.22 A; A=28-380, B=381-569.
DR   PDBsum; 4GDX; -.
DR   PDBsum; 4GG2; -.
DR   PDBsum; 4Z9O; -.
DR   PDBsum; 4ZBK; -.
DR   PDBsum; 4ZC6; -.
DR   PDBsum; 4ZCG; -.
DR   ProteinModelPortal; P19440; -.
DR   SMR; P19440; -.
DR   BioGrid; 108946; 8.
DR   IntAct; P19440; 2.
DR   MINT; MINT-2801579; -.
DR   STRING; 9606.ENSP00000248923; -.
DR   BindingDB; P19440; -.
DR   ChEMBL; CHEMBL5696; -.
DR   DrugBank; DB00143; Glutathione.
DR   SwissLipids; SLP:000001454; -.
DR   MEROPS; T03.006; -.
DR   iPTMnet; P19440; -.
DR   PhosphoSitePlus; P19440; -.
DR   BioMuta; GGT1; -.
DR   DMDM; 93140064; -.
DR   EPD; P19440; -.
DR   MaxQB; P19440; -.
DR   PaxDb; P19440; -.
DR   PeptideAtlas; P19440; -.
DR   PRIDE; P19440; -.
DR   DNASU; 2678; -.
DR   Ensembl; ENST00000248923; ENSP00000248923; ENSG00000100031. [P19440-1]
DR   Ensembl; ENST00000400380; ENSP00000383231; ENSG00000100031. [P19440-1]
DR   Ensembl; ENST00000400382; ENSP00000383232; ENSG00000100031. [P19440-1]
DR   Ensembl; ENST00000401885; ENSP00000384381; ENSG00000100031. [P19440-3]
DR   Ensembl; ENST00000403838; ENSP00000384820; ENSG00000100031. [P19440-3]
DR   Ensembl; ENST00000404532; ENSP00000385445; ENSG00000100031. [P19440-3]
DR   Ensembl; ENST00000425895; ENSP00000387499; ENSG00000100031. [P19440-2]
DR   GeneID; 2678; -.
DR   KEGG; hsa:2678; -.
DR   UCSC; uc003aan.2; human. [P19440-1]
DR   CTD; 2678; -.
DR   DisGeNET; 2678; -.
DR   GeneCards; GGT1; -.
DR   H-InvDB; HIX0016314; -.
DR   HGNC; HGNC:4250; GGT1.
DR   HPA; HPA045635; -.
DR   HPA; HPA047534; -.
DR   HPA; HPA065444; -.
DR   MalaCards; GGT1; -.
DR   MIM; 231950; phenotype.
DR   MIM; 612346; gene.
DR   neXtProt; NX_P19440; -.
DR   OpenTargets; ENSG00000100031; -.
DR   Orphanet; 33573; Gamma-glutamyl transpeptidase deficiency.
DR   PharmGKB; PA28662; -.
DR   eggNOG; KOG2410; Eukaryota.
DR   eggNOG; COG0405; LUCA.
DR   GeneTree; ENSGT00550000074591; -.
DR   HOGENOM; HOG000175620; -.
DR   HOVERGEN; HBG005835; -.
DR   InParanoid; P19440; -.
DR   KO; K18592; -.
DR   OMA; KPFMVIG; -.
DR   OrthoDB; EOG091G03Y3; -.
DR   PhylomeDB; P19440; -.
DR   TreeFam; TF313608; -.
DR   BioCyc; MetaCyc:MONOMER66-34394; -.
DR   Reactome; R-HSA-174403; Glutathione synthesis and recycling.
DR   Reactome; R-HSA-2142691; Synthesis of Leukotrienes (LT) and Eoxins (EX).
DR   Reactome; R-HSA-5423646; Aflatoxin activation and detoxification.
DR   SABIO-RK; P19440; -.
DR   UniPathway; UPA00204; -.
DR   ChiTaRS; GGT1; human.
DR   GeneWiki; GGT1; -.
DR   GenomeRNAi; 2678; -.
DR   PRO; PR:P19440; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100031; -.
DR   CleanEx; HS_GGT1; -.
DR   ExpressionAtlas; P19440; baseline and differential.
DR   Genevisible; P19440; HS.
DR   GO; GO:0031362; C:anchored component of external side of plasma membrane; TAS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0003840; F:gamma-glutamyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0036374; F:glutathione hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc.
DR   GO; GO:0019344; P:cysteine biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0006536; P:glutamate metabolic process; IDA:UniProtKB.
DR   GO; GO:0006750; P:glutathione biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0006751; P:glutathione catabolic process; IDA:UniProtKB.
DR   GO; GO:0006749; P:glutathione metabolic process; TAS:UniProtKB.
DR   GO; GO:0019370; P:leukotriene biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0006691; P:leukotriene metabolic process; TAS:Reactome.
DR   GO; GO:0002682; P:regulation of immune system process; ISS:UniProtKB.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   GO; GO:0031638; P:zymogen activation; IDA:UniProtKB.
DR   InterPro; IPR000101; GGT_peptidase.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   PANTHER; PTHR11686; PTHR11686; 1.
DR   Pfam; PF01019; G_glu_transpept; 1.
DR   PRINTS; PR01210; GGTRANSPTASE.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   TIGRFAMs; TIGR00066; g_glut_trans; 1.
DR   PROSITE; PS00462; G_GLU_TRANSPEPTIDASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acyltransferase; Alternative promoter usage;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glutathione biosynthesis;
KW   Glycoprotein; Hydrolase; Membrane; Polymorphism; Protease;
KW   Reference proteome; Sialic acid; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix; Zymogen.
FT   CHAIN         1    380       Gamma-glutamyltranspeptidase 1 heavy
FT                                chain.
FT                                /FTId=PRO_0000011058.
FT   CHAIN       381    569       Gamma-glutamyltranspeptidase 1 light
FT                                chain.
FT                                /FTId=PRO_0000011059.
FT   TOPO_DOM      1      4       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      5     26       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000305}.
FT   TOPO_DOM     27    569       Extracellular. {ECO:0000255}.
FT   REGION      451    452       Glutamate binding.
FT   ACT_SITE    381    381       Nucleophile.
FT                                {ECO:0000269|PubMed:17924658}.
FT   BINDING     107    107       Glutamate. {ECO:0000269|PubMed:24047895}.
FT   BINDING     399    399       Glutamate. {ECO:0000269|PubMed:24047895}.
FT   BINDING     420    420       Glutamate. {ECO:0000269|PubMed:24047895}.
FT   CARBOHYD     95     95       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:20622017,
FT                                ECO:0000269|PubMed:24047895}.
FT   CARBOHYD    120    120       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17924658,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973,
FT                                ECO:0000269|PubMed:20622017,
FT                                ECO:0000269|PubMed:24047895}.
FT   CARBOHYD    230    230       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:20622017,
FT                                ECO:0000269|PubMed:24047895}.
FT   CARBOHYD    266    266       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17924658,
FT                                ECO:0000269|PubMed:20622017,
FT                                ECO:0000269|PubMed:24047895}.
FT   CARBOHYD    297    297       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:20622017}.
FT   CARBOHYD    344    344       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17924658,
FT                                ECO:0000269|PubMed:20622017,
FT                                ECO:0000269|PubMed:24047895}.
FT   CARBOHYD    511    511       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15084671,
FT                                ECO:0000269|PubMed:17924658,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:20622017,
FT                                ECO:0000269|PubMed:24047895}.
FT   DISULFID     50     74       {ECO:0000269|PubMed:24047895}.
FT   DISULFID    192    196       {ECO:0000269|PubMed:24047895}.
FT   VAR_SEQ       1    344       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7689219}.
FT                                /FTId=VSP_008132.
FT   VAR_SEQ     341    366       VVRNMTSEFFAAQLRAQISDDTTHPI -> ASSGVSAGGPQ
FT                                HDLRVLRCPAPGPDL (in isoform 2).
FT                                {ECO:0000303|PubMed:1968061}.
FT                                /FTId=VSP_001746.
FT   VAR_SEQ     367    569       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:1968061}.
FT                                /FTId=VSP_001747.
FT   VARIANT      51     51       S -> L (in dbSNP:rs2330837).
FT                                /FTId=VAR_025545.
FT   VARIANT      52     52       K -> E (in dbSNP:rs2330838).
FT                                /FTId=VAR_018373.
FT   VARIANT     177    177       A -> V (in dbSNP:rs3895576).
FT                                /FTId=VAR_018374.
FT   VARIANT     272    272       V -> A (in dbSNP:rs4049829).
FT                                {ECO:0000269|PubMed:1378736,
FT                                ECO:0000269|PubMed:1968061,
FT                                ECO:0000269|PubMed:2563599,
FT                                ECO:0000269|PubMed:2568315,
FT                                ECO:0000269|PubMed:2904146,
FT                                ECO:0000269|PubMed:2907498}.
FT                                /FTId=VAR_018372.
FT   VARIANT     419    419       N -> D (in dbSNP:rs17004876).
FT                                /FTId=VAR_025546.
FT   VARIANT     435    435       V -> A (in dbSNP:rs16986465).
FT                                /FTId=VAR_049181.
FT   MUTAGEN     100    100       K->N: No effect on activity.
FT                                {ECO:0000269|PubMed:8095045}.
FT   MUTAGEN     102    102       E->Q: No effect on activity.
FT                                {ECO:0000269|PubMed:8095045}.
FT   MUTAGEN     107    107       R->K: Reduces enzyme activity by 99%.
FT                                {ECO:0000269|PubMed:8095045}.
FT   MUTAGEN     107    107       R->Q,H: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:8095045}.
FT   MUTAGEN     108    108       E->Q: Reduces enzyme activity by 98%.
FT                                {ECO:0000269|PubMed:8095045}.
FT   MUTAGEN     112    112       R->Q: No effect on activity.
FT                                {ECO:0000269|PubMed:8095045}.
FT   MUTAGEN     139    139       R->Q: No effect on activity.
FT                                {ECO:0000269|PubMed:8095045}.
FT   MUTAGEN     147    147       R->Q: No effect on activity.
FT                                {ECO:0000269|PubMed:8095045}.
FT   MUTAGEN     150    150       R->Q: No effect on activity.
FT                                {ECO:0000269|PubMed:8095045}.
FT   MUTAGEN     192    192       C->W: Loss of autocatalytic cleavage,
FT                                cell membrane localization and decrease
FT                                in catalytic activity; when associated
FT                                with Y-193.
FT                                {ECO:0000269|PubMed:23682772}.
FT   MUTAGEN     193    193       E->Y: Loss of autocatalytic cleavage,
FT                                cell membrane localization and decrease
FT                                in catalytic activity; when associated
FT                                with W-192.
FT                                {ECO:0000269|PubMed:23682772}.
FT   MUTAGEN     383    383       H->A: Reduces enzyme activity by 66%.
FT                                {ECO:0000269|PubMed:8827453}.
FT   MUTAGEN     385    385       S->A: No effect on activity.
FT                                {ECO:0000269|PubMed:7673200}.
FT   MUTAGEN     413    413       S->A: No effect on activity.
FT                                {ECO:0000269|PubMed:7673200}.
FT   MUTAGEN     422    422       D->A: Reduces enzyme activity by 90%.
FT                                {ECO:0000269|PubMed:7759490}.
FT   MUTAGEN     423    423       D->A: Abolishes enzyme activity.
FT                                Increases KM by over 1000-fold.
FT                                {ECO:0000269|PubMed:7759490}.
FT   MUTAGEN     425    425       S->A: No effect on activity.
FT                                {ECO:0000269|PubMed:7673200}.
FT   MUTAGEN     451    451       S->A: Reduces enzyme activity by 99%.
FT                                Abolishes activity; when associated with
FT                                A-452. {ECO:0000269|PubMed:7673200}.
FT   MUTAGEN     452    452       S->A: Reduces enzyme activity by 99%.
FT                                Abolishes activity; when associated with
FT                                A-451. {ECO:0000269|PubMed:7673200}.
FT   MUTAGEN     454    454       C->A: No effect on activity.
FT                                {ECO:0000269|PubMed:7759490}.
FT   MUTAGEN     505    505       H->A: Reduces enzyme activity by 90%.
FT                                {ECO:0000269|PubMed:8827453}.
FT   MUTAGEN     545    545       Q->K: Reduces enzyme activity by 97%.
FT                                {ECO:0000269|PubMed:24047895}.
FT   CONFLICT     30     31       SK -> KS (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     47     47       A -> K (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    139    139       R -> E (in Ref. 5; AAA35889).
FT                                {ECO:0000305}.
FT   CONFLICT    356    356       A -> S (in Ref. 10; AAI28240).
FT                                {ECO:0000305}.
FT   CONFLICT    361    361       D -> H (in Ref. 10; AAI28240).
FT                                {ECO:0000305}.
FT   CONFLICT    372    372       E -> D (in Ref. 7; AAA02886).
FT                                {ECO:0000305}.
FT   STRAND       36     40       {ECO:0000244|PDB:4GDX}.
FT   STRAND       42     44       {ECO:0000244|PDB:4GDX}.
FT   HELIX        48     59       {ECO:0000244|PDB:4GDX}.
FT   HELIX        64     78       {ECO:0000244|PDB:4GDX}.
FT   TURN         79     82       {ECO:0000244|PDB:4GDX}.
FT   STRAND       87     95       {ECO:0000244|PDB:4GDX}.
FT   TURN         96     99       {ECO:0000244|PDB:4GDX}.
FT   STRAND      100    106       {ECO:0000244|PDB:4GDX}.
FT   HELIX       122    126       {ECO:0000244|PDB:4GDX}.
FT   HELIX       129    131       {ECO:0000244|PDB:4GDX}.
FT   HELIX       137    148       {ECO:0000244|PDB:4GDX}.
FT   HELIX       153    166       {ECO:0000244|PDB:4GDX}.
FT   HELIX       172    180       {ECO:0000244|PDB:4GDX}.
FT   HELIX       182    187       {ECO:0000244|PDB:4GDX}.
FT   HELIX       189    195       {ECO:0000244|PDB:4GDX}.
FT   STRAND      206    208       {ECO:0000244|PDB:4GDX}.
FT   HELIX       211    223       {ECO:0000244|PDB:4GDX}.
FT   HELIX       226    229       {ECO:0000244|PDB:4GDX}.
FT   HELIX       234    243       {ECO:0000244|PDB:4GDX}.
FT   HELIX       250    255       {ECO:0000244|PDB:4GDX}.
FT   STRAND      259    263       {ECO:0000244|PDB:4GDX}.
FT   STRAND      265    269       {ECO:0000244|PDB:4GDX}.
FT   STRAND      272    276       {ECO:0000244|PDB:4GDX}.
FT   HELIX       283    294       {ECO:0000244|PDB:4GDX}.
FT   HELIX       300    303       {ECO:0000244|PDB:4GDX}.
FT   HELIX       306    327       {ECO:0000244|PDB:4GDX}.
FT   TURN        333    335       {ECO:0000244|PDB:4GDX}.
FT   HELIX       339    345       {ECO:0000244|PDB:4GDX}.
FT   HELIX       348    355       {ECO:0000244|PDB:4GDX}.
FT   HELIX       366    369       {ECO:0000244|PDB:4GDX}.
FT   STRAND      382    387       {ECO:0000244|PDB:4GDX}.
FT   STRAND      393    399       {ECO:0000244|PDB:4GDX}.
FT   TURN        403    406       {ECO:0000244|PDB:4GDX}.
FT   STRAND      407    409       {ECO:0000244|PDB:4ZC6}.
FT   TURN        411    413       {ECO:0000244|PDB:4GDX}.
FT   HELIX       420    423       {ECO:0000244|PDB:4GDX}.
FT   STRAND      427    429       {ECO:0000244|PDB:4Z9O}.
FT   STRAND      432    434       {ECO:0000244|PDB:4Z9O}.
FT   HELIX       439    441       {ECO:0000244|PDB:4GDX}.
FT   STRAND      456    460       {ECO:0000244|PDB:4GDX}.
FT   STRAND      465    476       {ECO:0000244|PDB:4GDX}.
FT   HELIX       477    489       {ECO:0000244|PDB:4GDX}.
FT   HELIX       495    500       {ECO:0000244|PDB:4GDX}.
FT   STRAND      508    511       {ECO:0000244|PDB:4GDX}.
FT   STRAND      513    515       {ECO:0000244|PDB:4GDX}.
FT   HELIX       521    529       {ECO:0000244|PDB:4GDX}.
FT   STRAND      534    536       {ECO:0000244|PDB:4GDX}.
FT   STRAND      543    550       {ECO:0000244|PDB:4GDX}.
FT   STRAND      553    557       {ECO:0000244|PDB:4GDX}.
FT   TURN        560    562       {ECO:0000244|PDB:4GDX}.
SQ   SEQUENCE   569 AA;  61410 MW;  71AE12485239A69F CRC64;
     MKKKLVVLGL LAVVLVLVIV GLCLWLPSAS KEPDNHVYTR AAVAADAKQC SKIGRDALRD
     GGSAVDAAIA ALLCVGLMNA HSMGIGGGLF LTIYNSTTRK AEVINAREVA PRLAFATMFN
     SSEQSQKGGL SVAVPGEIRG YELAHQRHGR LPWARLFQPS IQLARQGFPV GKGLAAALEN
     KRTVIEQQPV LCEVFCRDRK VLREGERLTL PQLADTYETL AIEGAQAFYN GSLTAQIVKD
     IQAAGGIVTA EDLNNYRAEL IEHPLNISLG DVVLYMPSAP LSGPVLALIL NILKGYNFSR
     ESVESPEQKG LTYHRIVEAF RFAYAKRTLL GDPKFVDVTE VVRNMTSEFF AAQLRAQISD
     DTTHPISYYK PEFYTPDDGG TAHLSVVAED GSAVSATSTI NLYFGSKVRS PVSGILFNNE
     MDDFSSPSIT NEFGVPPSPA NFIQPGKQPL SSMCPTIMVG QDGQVRMVVG AAGGTQITTA
     TALAIIYNLW FGYDVKRAVE EPRLHNQLLP NVTTVERNID QAVTAALETR HHHTQIASTF
     IAVVQAIVRT AGGWAAASDS RKGGEPAGY
//
